CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer. (Q30010476)
Jump to navigation
Jump to search
scientific article published on 23 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer. |
scientific article published on 23 June 2011 |
Statements
CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer (English)
Renjini Ambika Padmanabhan
Lini Nirmala
Malini Laloraya
1 reference
1 reference
1 reference